Ghoul
Member
I agree with the neutral effect, just referring to your claim of "Uniquely, it doesn't increase insulin resistance like other statins, and often improves it(!)."
A Statin that improves Homa got my immediate curiosity so i wanted to follow up on that and learn more!
I think the LDL reduction could be interesting for some people but generally speaking i would always try and stay away from Statins as much as possible. I did not have the intentions to look for downsides of Pitavastatin, the only one i could think of is the cost and availability given that they only come in 30 Pills boxes within Europe and cost nearly 80-90€. For an insurance to cover it most of the time a extended period of "testing and trialing" is needed, so you might need to complain a lot to your doc to approve the switch
I think Pitavastatin great, just alone for the Insulin resistance part which seems to be untouched and the stronger effect of plaque reduction plus the different way it gets metabolized in the liver
I sincerely appreciate your thoughtful response.
I found it easier to get my doctor to prescribe Repatha than Pitavastatin. I thought I must be missing something negative about it, but concluded it was clinical inertia.
When I finally met with a Preventative Cardiologist, who treats a pro sports team in his practice outside the University health system I use, he confirmed my conclusions about Pita. Despite the massive drop in cost in the US, he thinks it'll be a decade or more before its use becomes common,
Same with plaque regression. Clearly this is a primary focus of cardiology now that "stabilizing" plaque has conclusively been proven to offer massive benefits, regression is the next logical step.
Pita leaves that regression window open longer than other statins, which induce rapid calcification. That's great for quick risk reduction by stabilizing plaque so it can't break off causing a clot, but where there's no imminent danger, reducing the narrowing of arteries as much as possible before sealing it by accelerating the formation of an arterial "rock tube" is my personal target. I'm not waiting for another decade of trials, and am willing to roll the dice on that one.
Sometimes when choosing a drug, there really aren't any tradeoffs between them. Cilnidipine is clearly superior to Amlodipine, with no (medical) reason to ever pick the latter. It seems to me Pita vs every other statin is another example.
Last edited:
